Autolus Therapeutics Reports Third Quarter 2021 Financial Results and Operational Progress

NEXT STORY
Agios Reports Business Highlights and Third Quarter 2021 Financial Results
PREV STORY
Teleflex Comments on the Centers for Medicare & Medicaid Services 2022 Medicare Physician Fee Schedule Final Rule
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immunotech Laboratories, Inc. / ECPO Year End Update and Announces Appointment of Dr. Hongxiang Hui to the Advisory Board

MONROVIA, CA, Dec. 22, 2017 (GLOBE NEWSWIRE) --  Immunotech Laboratories, Inc. f/k/a Eco-Petroleum Solutions, ...

author_avatar
NASDAQ Market News

Immune Design to Present at Upcoming Investor Conferences

SEATTLE and SOUTH SAN FRANCISCO, Calif., Feb. 10, 2017 (GLOBE NEWSWIRE) -- Immune Design ...

author_avatar
NASDAQ Market News

NanoVibronix Announces Exclusive Agreement for Distribution of PainShield® and WoundShield® in Israel

ELMSFORD, N.Y., June 05, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ:NAOV), a medical device ...

author_avatar
NASDAQ Market News